Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Bearish
2
Neutral
7
Bullish
5
Bearish
9
Neutral
15
Bullish
22
Bearish
7
Neutral
8
Bullish
17
Discovery themes featuring this stock
Fertilizers & Agrochemicals
Pesticides & Agrochemicals
440 Cr
Low Risk
31.2
22.3
0.5
3.9
205.05
111.00
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
111.79 | 732 Cr | 19.61 | 2.49 | 0.00 | — | — | 0.00 | ||
13.58 | 649 Cr | 13.35 | 0.89 | 1.09 | 1.58 | 6.54 | 1.23 | ||
187.02 | 486 Cr | 13.34 | 1.33 | 0.00 | 10.09 | 14.71 | 0.00 | ||
160.00 | 440 Cr | 21.05 | 3.87 | 0.00 | 24.39 | 20.67 | 5.96 | ||
236.40 | 435 Cr | 32.47 | 0.74 | 0.18 | 2.40 | 4.84 | 1.99 | ||
63.07 | 414 Cr | 10.08 | 0.94 | 0.00 | 8.63 | 10.37 | 4.41 | ||
4.94 | 207 Cr | 53.29 | 2.40 | 0.00 | 6.32 | 8.11 | 4.59 | ||
| Median: 7 Co. | — | 111.79 | 440 Cr | 19.61 | 1.33 | 0.00 | 7.48 | 9.24 | 1.99 |
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Mahamaya Lifesciences Ltd (MAHALIFE) is currently trading at 186.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Mahamaya Lifesciences Ltd operates in the its sector sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.
Over the past 52 weeks, Mahamaya Lifesciences Ltd has traded between a low of ₹111.00 and a high of ₹205.05. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Mahamaya Lifesciences Ltd has a market capitalization of approximately 439.55. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Mahamaya Lifesciences Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 31.24 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 439.55 Cr, Mahamaya Lifesciences Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Mahamaya Lifesciences Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Mahamaya Lifesciences Ltd is 31.24. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
